Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | BLM | P54132 | 1/20 | 0.54 |
| ▸ | AGER | Q15109 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | ASPH | Q12797 | 1/20 | 0.50 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 3/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | MYC | P01106 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL335807 | 0.97 | KDM4E (0.52) | KDM4EMAPTALDH1A1TSHRL3MBTL1 | |
| SCHEMBL28058447 | 0.97 | KDM4E (0.52) | KDM4EMAPTALDH1A1TSHRL3MBTL1 | |
| Hydrochloric Acid SCHEMBL9356773 | 0.97 | KDM4E (0.52) | KDM4EMAPTALDH1A1TSHRL3MBTL1 | |
| SCHEMBL6345905 | 0.97 | KDM4E (0.52) | KDM4EMAPTALDH1A1TSHRL3MBTL1 | |
| SCHEMBL27875395 | 0.97 | KDM4E (0.52) | KDM4EMAPTALDH1A1TSHRL3MBTL1 | |
| SCHEMBL29113117 | 0.97 | KDM4E (0.52) | KDM4EMAPTALDH1A1TSHRL3MBTL1 | |
| Hydrochloric Acid SCHEMBL9356765 | 0.97 | KDM4E (0.52) | KDM4EMAPTALDH1A1TSHRL3MBTL1 | |
| Iodide SCHEMBL28827358 | 0.94 | KDM4E (0.52) | KDM4EMAPTALDH1A1TSHRL3MBTL1 | |
| Formic Acid SCHEMBL27879436 | 0.89 | KDM4E (0.46) | KDM4EMAPTALDH1A1TSHRL3MBTL1 | |
| SCHEMBL9630721 | 0.89 | KDM4E (0.48) | KDM4EMAPTALDH1A1TSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1980 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260131307-A1 | Bi-Metallic Pillared-Layered Coordination Polymers for Carbon Dioxide Removal | UNIV OF PUERTO RICO (US) | 2026-05-14 | — | — | US | claimed |
| EP-4547732-B1 | POLYESTER POLYMER FOR USE IN HAIR CARE | SYENSQO SA (BE) | 2026-05-06 | — | — | EP | claimed |
| US-20260104618-A1 | PRODUCTION METHOD FOR NANOPARTICLES USED FOR LIGHT VALVES OF DIFFERENT COLORS, LIGHT VALVES OF DIFFERENT COLORS AND APPLICATION THEREOF | SMART LIQUID CRYSTAL TECHNOLOGIES CO., LTD. (CN) | 2026-04-16 | — | — | US | claimed |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| US-12515195-B2 | Bi-metallic pillared-layered coordination polymers for carbon dioxide removal | UNIVERSITY OF PUERTO RICO | 2026-01-06 | — | — | US | claimed |
| US-20250354659-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | NUOVO PIGNONE TECNOLOGIE – S R L (IT) | 2025-11-20 | — | — | US | claimed |
| WO-2025238576-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | Nuovo Pignone Tecnologie – S.r.l. (IT) | 2025-11-20 | — | — | WO | claimed |
| EP-4572884-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | General Electric Technology GmbH (CH) | 2025-06-25 | — | — | EP | claimed |
| WO-1995019162-A1 | ESTRADIOL PENETRATION INTENSIFIER FOR TRANSDERMAL ADMINISTRATION | LTS LOHMANN THERAPIE-SYSTEME GMBH & CO. KG (DE) | 1995-07-20 | — | — | WO | claimed |
| WO-1995001990-A1 | HEMOREGULATORY PENTA- OR HEXAPEPTIDES | NYCOMED PHARMA A.S (NO) | 1995-01-19 | — | — | WO | claimed |
| WO-1994028028-A1 | TOPOLOGICALLY SEGREGATED, ENCODED SOLID PHASE LIBRARIES | SELECTIDE CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
| EP-0425344-B1 | Light polarizing materials and suspensions thereof | RESEARCH FRONTIERS INC (US) | 1994-05-18 | — | — | EP | claimed |
| EP-0580880-A1 | Control of anisotropic silicon etching utilizing a selected catalyzed etchant | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1994-02-02 | — | — | EP | claimed |
| WO-1993014427-A1 | LIGHT-POLARIZING MATERIALS, AND METHOD FOR MANUFACTURING THE MATERIALS | HANKUK GLASS INDUSTRIES, INC. (KR) | 1993-07-22 | — | — | WO | claimed |
| EP-0551136-A1 | Light-polarizing materials, and method for manufacturing the materials | HANKUK GLASS INDUSTRIES, INC. (KR) | 1993-07-14 | — | — | EP | claimed |
| EP-0145506-B1 | ELIMINATION OF DEFECTS IN CYSTEINE-SENSITIZED EMULSIONS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-03-02 | — | — | EP | claimed |
| US-4514492-A | Elimination of defects in cysteine-sensitized emulsions | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-04-30 | — | — | US | claimed |
| US-4120762-A | POROUS SUPPORT IMPREGNATED WITH AN ELECTROLYTE, A MARKING COMPOUND AND A NITROGEN-CONTAINING SIX-MEMBERED HETEROCYCLIC AROMATIC CARBOXY ACID | ALDEN RESEARCH FOUNDATION (US) | 1978-10-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260104618-A1 | PRODUCTION METHOD FOR NANOPARTICLES USED FOR LIGHT VALVES OF DIFFERENT COLORS, LIGHT VALVES OF DIFFERENT COLORS AND APPLICATION THEREOF | VCL, NECTIN4, TTN | KDM4E 4436/4885MAPT 1671/4885ALDH1A1 983/4885 |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | KDM4E 421/4885MAPT 1454/4885ALDH1A1 3451/4885 |
| US-20260131307-A1 | Bi-Metallic Pillared-Layered Coordination Polymers for Carbon Dioxide Removal | MAP2K4, MAP2K1, MAP2K2 | KDM4E 66/4885MAPT 1941/4885ALDH1A1 2449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.